L. Chu

发表

Complete eradication of xenograft hepatoma by oncolytic adenovirus ZD55 harboring TRAIL-IETD-Smac gene with broad antitumor effect.

W. Qian, Xin-Yuan Liu, Kang-Jian Zhang, 2012, Human gene therapy.

Oncolytic adenovirus-mediated shRNA against Apollon inhibits tumor cell growth and enhances antitumor effect of 5-fluorouracil

C. Qian, J. Gu, Q. Qian, 2008, Gene Therapy.

Multiple myeloma-associated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stress.

S. Crosby, R. Vij, M. Tomasson, 2012, The Journal of clinical investigation.

Adenoviral vector expressing CYLD augments antitumor activity of TRAIL by suppression of NF-κB survival signaling in hepatocellular carcinoma

Xinyuan Liu, Zhong He, L. Chu, 2006, Cancer biology & therapy.

Acetylcholinesterase overexpression mediated by oncolytic adenovirus exhibited potent anti-tumor effect

Haineng Xu, Xin-Yuan Liu, Yizhun Zhu, 2014, BMC Cancer.

Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter.

W. Tan, Xin Yuan Liu, L. Chu, 2009, Cancer letters.

Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors.

E. Svensson, J. Leiden, D. Marshall, 1999, Circulation.

Xin-Yuan Liu, Kang-Jian Zhang, Xiu-mei Zhou, 2016, Protein & Cell.

Oncolytic Adenovirus Complexes Coated with Lipids and Calcium Phosphate for Cancer Gene Therapy.

Y. Duan, Ying Sun, Li Ding, 2016, ACS nano.

An oncolytic adenovirus that expresses the HAb18 and interleukin 24 genes exhibits enhanced antitumor activity in hepatocellular carcinoma cells

Xin-Yuan Liu, L. Chu, Sujing Yuan, 2016, Oncotarget.

Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector.

E. Svensson, J. Leiden, E. Goldwasser, 1997, Human gene therapy.

An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice

C. Qian, R. Qi, W. Zou, 2004, Hepatology.

c-MYC responds to glucose deprivation in a cell-type-dependent manner

X. Liu, L. Li, L. Chu, 2015, Cell Death Discovery.

Thioridazine has potent antitumor effects on lung cancer stem-like cells

Haineng Xu, Yigang Wang, L. Chu, 2017, Oncology letters.

Ferroptosis and tumor immunotherapy: A promising combination therapy for tumors

L. Chu, Huazhong Cai, Shuangwei Chen, 2023, Frontiers in Oncology.

Transcriptional targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo.

J. Leiden, M. Parmacek, S. Kim, 1997, The Journal of clinical investigation.

Multiple origins of spontaneously arising micronuclei in HeLa cells: direct evidence from long-term live cell imaging.

M. Fenech, Yun Huang, Bo Xu, 2008, Mutation research.

Possibility to Partly Win the War Against Cancer

Yi Chen, J. Ouyang, Ying Cai, 2012 .

SNORD126 promotes HCC and CRC cell growth by activating the PI3K–AKT pathway through FGFR2

Xin-Yuan Liu, Kang-Jian Zhang, L. Chu, 2016, Journal of molecular cell biology.

Transmembrane domain is crucial to the subcellular localization and function of Myc target 1

Q. Pan, Xinyuan Liu, L. Chu, 2015, Journal of cellular and molecular medicine.

Germinal Center B-Cells Resist Transformation by Kras Independently of Tumor Suppressor Arf

R. Vij, S. Kulkarni, M. Tomasson, 2013, PloS one.

Cancer Targeting Gene-Viro-Therapy and Its Promising Future: A Trend in Both Cancer Gene Therapy and Cancer Virotherapy

Wenlin Huang, Q. Qian, W. Zou, 2012 .

Potent and Specific Antitumor Effect for Colorectal Cancer by CEA and Rb Double Regulated Oncolytic Adenovirus Harboring ST13 Gene

Yue Zhang, Shu Zheng, Xinyuan Liu, 2012, PloS one.

AKT pathway through FGFR 2

Xin-Yuan Liu, Kang-Jian Zhang, L. Chu, 2016 .

An Oncolytic Adenovirus Expressing SNORD44 and GAS5 Exhibits Antitumor Effect in Colorectal Cancer Cells.

Yuehua Wu, Yigang Wang, L. Chu, 2017, Human gene therapy.

Whole Genome Sequence of Multiple Myeloma-Prone C57BL/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types

G. Colditz, C. Vachon, D. Serie, 2015, PloS one.

RGD-modifided oncolytic adenovirus exhibited potent cytotoxic effect on CAR-negative bladder cancer-initiating cells

L. Chu, H. Xu, J. Shen, 2015, Cell Death and Disease.

Lithium Down-regulates Histone Deacetylase 1 (HDAC1) and Induces Degradation of Mutant Huntingtin*

Xin-Yuan Liu, Kang-Jian Zhang, L. Chu, 2013, The Journal of Biological Chemistry.

RGD-modified oncolytic adenovirus-harboring shPKM2 exhibits a potent cytotoxic effect in pancreatic cancer via autophagy inhibition and apoptosis promotion

Zhi-nan Chen, Zongsuo Liang, Xin-Yuan Liu, 2017, Cell Death & Disease.

A Potent In Vivo Antitumor Efficacy of Novel Recombinant Type I Interferon

S. Fuchs, Kanstantsin V. Katlinski, Xin-Yuan Liu, 2016, Clinical Cancer Research.

Survive or die? c-MYC has the last word

X. Liu, L. Chu, X. Yin, 2015, Cell Death and Disease.

Xin-Yuan Liu, Kang-Jian Zhang, Xiu-mei Zhou, 2016, Protein & Cell.

Synergistic antitumoral effects of human telomerase reverse transcriptase‐mediated dual‐apoptosis‐related gene vector delivered by orally attenuated Salmonella enterica Serovar Typhimurium in murine tumor models

Xinyuan Liu, D. Ren, W. Fu, 2008, The journal of gene medicine.

Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus

Yu Yang, Haineng Xu, Xin-Yuan Liu, 2015, Journal of cellular and molecular medicine.